RESTASIS
- Product NDC
- 50090-1242
- 11-digit product format
- 500901242
- Labeler code
- 50090
- Product ID
- 50090-1242_2af9d19d-a029-4d25-9d01-99e7caf324a8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- cyclosporine
- Dosage form
- EMULSION
- Route
- OPHTHALMIC
- Labeler
- A-S Medication Solutions
- Application
- NDA050790
- Marketing category
- NDA
- Marketing start
- 2003-04-01
- Marketing end
- 0000-00-00
- Substance
- CYCLOSPORINE
- Active strength
- 1 mg/mL
- Pharmacologic classes
- Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50090-1242-0 | RESTASIS | 30 in 1 TRAY | EMULSION | 30 | | 16 |
| 50090-1242-0 | RESTASIS | .4 mL in 1 VIAL, SINGLE-USE | EMULSION | .4 | | 16 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50090-1242 | RESTASIS (CYCLOSPORINE) EMULSION [A-S MEDICATION SOLUTIONS] | 16 | Legacy NDC, 2 package rows | 20210415_ce9325ab-fca1-4dae-8e53-a46ec95d3a76.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-1242-0 | 50090124200 | 30 VIAL, SINGLE-USE in 1 TRAY (50090-1242-0) > .4 mL in 1 VIAL, SINGLE-USE | 2014-11-28 | 0000-00-00 | No | No | Current |